Author: Bykov, Vladimir J. N.; Issaeva, Natalia; Zache, Nicole; Shilov, Alexandre; Hultcrantz, Monica; Bergman, Jan; Selivanova, Galina; Wiman, Klas G.
Description: Reactivation of mutant p53 is likely to provide important benefits for treatment of chemotherapy- and radiotherapy-resistant tumors. We demonstrate here that the maleimide-derived molecule MIRA-1 can reactivate DNA binding and preserve the active conformation of mutant p53 protein in vitro and restore transcriptional transactivation to mutant p53 in living cells. MIRA-1 induced mutant p53-dependent cell death in different human tumor cells carrying tetracycline-regulated mutant p53. The structural analog MIRA-3 showed antitumor activity in vivo against human mutant p53-carrying tumor xenografts in SCID mice. The MIRA scaffold is a novel lead for the development of anticancer drugs specifically targeting mutant p53.
Subject headings: Animals; Antineoplastic Agents; Cell Line; Tumor; Cell Separation; DNA; Dose-Response Relationship; Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glutathione Transferase; Humans; Maleimides; Mice; Mice, SCID; Microscopy; Fluorescence; Models, Chemical; Mutation; Neoplasm Transplantation; Neoplasms; Plasmids; Protein Binding; Protein Conformation; Tetracycline; Transcriptional Activation; Tumor Suppressor Protein p53
Publication year: 2005
Journal or book title: The Journal of Biological Chemistry
Volume: 280
Issue: 34
Pages: 30384-30391
Find the full text: https://www.strategian.com/fulltext/Bykov2005.pdf
Find more like this one (cited by): https://scholar.google.com/scholar?cites=6141444408780308403&as_sdt=1000005&sciodt=0,16&hl=en
Serial number: 4014